the market?
Novartis
NYSE: NVS
74.15
-0.86
(-1.15%)
| Today's Open | $73.53 |
|---|---|
| Previous Close | $75.01 |
| Daily Range | $73.50 - $74.16 |
| 52-Week Range | $51.20 - $75.67 |
| Market Cap | $182.2B |
| P/E Ratio | 19.28 |
| Dividend (Yield) | $2.53 (2.7%) |
| Ex-Dividend Date Dividend Pay Date |
02/26/13 04/05/13 |
| Volume | 1,092,063 |
| Average Daily Volume | 1,481,047 |
| Current FY EPS | $5.11 |
How do you think NVS
will perform against the market?
Top NVS Bull/Bear Pitches
MarginofSafetyIn (< 20)
Submitted
November 21, 2010
Novartis Review: Could be a good pharma pick Intro Novartis is a “large Pharma” company with 5 major operating units: Branded pharmaceuticals, Generic pharmaceuticals, diagnostics, vaccines and follo … More
News & Commentary
3 Companies That Put the "Tech" in "Biotech"
From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."Angelina Jolie's Selfless Act Heightens Breast Cancer Awareness
Jolie's personal experiences brings the dangers of breast cancer into new light and also gives hope to current and future breast cancer sufferers thanks to improving therapies and diagnostic tests.The Hidden Opportunity of the Novel Coronavirus
With the potential for an epidemic at hand, we look at things from a glass-half-full perspective.Sector
Healthcare
Industry
Drugs
Novartis (NVS) Description
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/
CEO Rating by Glassdoor
More details for Novartis Jobs
Novartis reviews from employees
